• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS LIPC; LIPASE TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS LIPC; LIPASE TEST SYSTEM Back to Search Results
Catalog Number 07041918190
Device Problems High Test Results (2457); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/23/2022
Event Type  malfunction  
Manufacturer Narrative
Na.
 
Event Description
The initial reporter stated they received questionable results for one patient sample tested with the lipc (lipase colorimetric) assay on two cobas 8000 c702 modules (serial numbers (b)(4).The results of the sample did not agree with other clinical findings of the patient.On (b)(6) 2022, the sample was initially tested on c702 serial number (b)(4), resulting in an lipc value of 738.4 u/l, accompanied by a data flag.The sample was repeated with a reduced volume, resulting in an lipc value of 900.3 u/l.Based on this result, the patient was hospitalized again.On (b)(6) 2022, a sample of the patient was tested in the hospital with an unknown method, resulting in a lipase value of 97.No unit of measure was provided.On (b)(6) 2022, the sample from (b)(6) 2022 was repeated on c702 serial number (b)(4), resulting in an lipc value of 758.4 u/l, accompanied by a data flag.The sample was repeated with a reduced volume, resulting in an lipc value of 927.8 u/l.The result of (b)(6) 2022 was deemed to be "too high" and clinically not possible.The questionable result was reported outside of the laboratory.
 
Manufacturer Narrative
Calibration results were acceptable.Quality controls were within specification.Interference with respect to the patient's acetaminophen or fluvermal medication can be excluded.Based on the available data, a general reagent issue can be excluded.The investigation could not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPC
Type of Device
LIPASE TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16003761
MDR Text Key308191592
Report Number1823260-2022-04071
Device Sequence Number1
Product Code CHI
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Catalogue Number07041918190
Device Lot Number647171
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/25/2022
Initial Date FDA Received12/19/2022
Supplement Dates Manufacturer Received01/20/2023
Supplement Dates FDA Received02/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ACETAMONIPHEN; FLUVERMAL
Patient Age12 YR
Patient SexMale
-
-